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Background: Major depression and depressive symptoms are common in patients with a recent myocardial
infarction (MI), and depression is associated with adverse cardiovascular outcomes. Anxiety post-MI is less studied,
but occurs commonly in patients with heart disease, and is also considered a risk factor for recurrence of cardiac
events. Cognitive behavior therapy (CBT) is an established therapy for depression and anxiety disorders. To the
best of our knowledge, there have not been any studies to determine if internet-based CBT (iCBT) can reduce
the symptoms of depression and anxiety in patients with a recent MI. The main aim of the U-CARE Heart trial is
to evaluate an iCBT intervention for patients with a recent MI.
Methods/design: This is a randomized, controlled, prospective study with a multicenter design. A total of 500
participants will be randomized at a 1:1 ratio, around two months after an acute MI, to either iCBT or to a control
group. Both groups will receive an optimal standard of care according to guidelines. The intervention consists of
a self-help program delivered via the internet with individual online support from a psychologist. Treatment
duration is 14 weeks. The primary outcome is change in patients’ self-rated anxiety and depression symptoms
from baseline to end of treatment. An internal pilot study was conducted indicating sufficient levels of study
acceptability and engagement in treatment.
Discussion: The present study is designed to evaluate an iCBT intervention targeting symptoms of depression
and anxiety in a post-MI population. If effective, iCBT has several advantages, and will potentially be implemented
as an easily accessible treatment option added to modern standard of care.
Trial registration: This trial was registered with Clinicaltrials.gov (identifier: NCT01504191) on 19 December 2011.
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Depression and anxiety is common in patients with
myocardial infarction
Depression and depressive symptoms are common in
patients with a recent myocardial infarction (MI). Major
depression is reported to be prevalent in 20% of this
patient population and, when including subsyndromal
depressive symptoms, the prevalence is 31% [1]. Depression
is also associated with adverse cardiovascular (CV) out-
comes [2]. Furthermore, depression is a chronic, disabling
condition associated with poor quality of life, functional
limitation, less favorable self-care behaviors, and higher
health care costs among patients with heart disease [3].
There are several possible mechanisms linking depression
to cardiac events. Smoking and hypertension are known
risk factors for heart disease that are more prevalent
in depressed patients [4,5]. Depression is also associated
with poor adherence to cardiac rehabilitation, which may
lead to a less optimal recovery and worsened prognosis
[6]. In addition, depression is an independent risk fac-
tor for future events. Possible mechanisms may be
neuroendocrine dysfunction, disturbances in autonomic
cardiac control, enhanced platelet activity, endothelial
dysfunction, and inflammation [2].
Anxiety in patients with a recent MI and its association
with prognosis has been less studied than depression, and
the prevalence of patients diagnosed with anxiety is
therefore uncertain. However, in one study, 38% of a
post-MI group reported at least mild symptoms of
anxiety, while only 18% in the same population reported
at least mild symptoms of depression [7]. Importantly, in a
large meta-analysis it was concluded that anxiety was not
only common after MI, but also an independent risk
factor for incident coronary heart disease and cardiac
mortality [8]. Assumed mechanisms connecting anxiety
and MI are more rapid progression of atherosclerosis,
increased risk of ventricular arrhythmias, and unhealthier
lifestyle factors, which are common among patients
with anxiety and are known risk factors for heart
disease [9]. Feelings of anxiety, sadness, and anger
and/or hostility are highly correlated, and all are con-
sidered risk factors for first and recurrent cardiac
events. It’s been suggested that at general disposition
toward negative affectivity may be a more important
risk factor than the expression of any specific negative
affect [10].
Psychological interventions for patients with a recent
myocardial infarction
Psychological interventions may reduce the level of
depression in cardiac patients according to a Cochrane
review [11], and of the psychological interventions,
cognitive behavioral therapy (CBT) has shown the
most favorable results [12]. Despite the fact that anxiety isa risk factor for MI, very few treatment studies on anxiety
in patients with a recent MI have been conducted [11]. To
our knowledge, there is only one randomized controlled
clinical trial (RCT), which showed no effect of the
intervention [13]. There are several studies that have
used group-based interventions focusing on a broader
range of psychosocial risk factors with good results. These
studies use CBT principles in a cognitive behavioral stress
management program [14-16].
There is a high degree of spontaneous recovery of anxiety
and depression in the first month after an MI [17]. By
delaying the start of the treatment by two to three months
after the acute event, one can exclude those who recover
spontaneously from an initial depression or crisis and
minimize the risk of treating people who will recover
spontaneously. In the ENRICHD-study, therapy started two
weeks after the MI, which led to substantial recovery in
both the treatment group and the control group [18].Internet-based cognitive behavioral therapy
During the past decade, internet-delivered psychological
interventions have become more common, and internet-
based CBT (iCBT) has several advantages over traditional
face-to-face CBT. First, the treatment can be delivered at
any preferred time and place, and participants can work
with the material at their own pace and review it as often
as desired. Second, the level of therapist involvement can
be adjusted and individualized; thus it may be possible to
reduce the therapist time while maintaining efficacy [19].
Importantly, iCBT has been shown to be as effective as
traditional CBT when it comes to anxiety and depression
[19]. To achieve good compliance and results when
delivering iCBT, individual support by psychologists is
recommended [20]. It also seems beneficial to tailor
the intervention towards specific problems in the target
population instead of using generic treatments [21].
Although there are fewer studies available for iCBT, it
seems to work well in populations with various somatic
disorders [22]. To our knowledge, there are no RCTs
available to determine the effects of iCBT in patients with
a recent MI.Study objectives
The aim of the U-CARE Heart trial is to prospectively
study the effects of iCBT in male and female patients
with a recent MI with symptoms of depression and anxiety.
Primary endpoints are change in self-rated depression and
anxiety. Secondary endpoints are quality of life, stress
behaviors, fatigue, sleep pattern, posttraumatic stress,
and posttraumatic growth. Furthermore, we will evaluate
health economy aspects and the cost-effectiveness of the
intervention, and study its effect on later major adverse
cardiac events.
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The present study is part of the Uppsala University
Psychosocial Care Program (U-CARE), which aims at
developing psychosocial care for somatic disease via the
internet [23]. An internet platform (the U-CARE portal,
Uppsala University, Uppsala, Sweden) has been developed
within the U-CARE program. The U-CARE portal is
used for data collection and interventions in all projects
undertaken within the framework of the program.
Study design and participants
U-CARE Heart is a prospective RCT. Figure 1 provides
an outline of the trial design. A total of 500 participants
will be recruited in a multicenter design, involving
cardiology clinics in Sweden, in both rural and urban
areas. Currently, 15 hospitals are engaged in the study.
Inclusion and exclusion criteria are:Screened for eligibility
1 – 8 weeks post MI 
Baseline assessment








5 month post MI
(3 month after baseline assessment)
Follow up assessment and
medical data obtained from register
12 month post MI
Medical data obtained from register
24 months post MI
Figure 1 U-CARE Heart overall study design. HADS, Hospital Anxiety an
MI, myocardial infarction.Inclusion criteria
 Age <75-years-old with a recent acute MI
(<3 months)
 Depression and/or anxiety score of >7 on one or
both of the Hospital Anxiety and Depression Scale
(HADS) subscales [24].
Exclusion criteria
 Scheduled for a coronary artery bypass surgery
 Unable or unwilling to use a computer or internet,
including email
 Unable or unwilling to use a mobile phone
 Difficulties in reading or understanding Swedish
 Life expectancy of less than a year
 Anticipated poor complianceExcluded
• Declines participation





severely depressed or suicidal
patients
Allocated to reference group
s
s 
d Depression Scale; iCBT, internet-based cognitive behavioral therapy;
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Åsberg Depression Rating Scale Self Rating
(MADRS-S) score >34 or MADRS-S item 9 > 3) [25]
 Participation in an ongoing trial with a behavioral
intervention.
Participants scoring below eight on the HADS; will be
allocated to a reference group which will be used to
answer correlational research questions that are beyond
the scope of this paper describing the RCT. Participants,
both in the intervention group and in the control group,
may seek other help such as psychopharmacology or
counselling for their emotional problems if they wish to.
Information on other treatment will be collected and
controlled for in the statistical analyses. The first 20 ran-
domized patients were included in an internal pilot
study reported below. At that time of the pilot study, 12
hospitals were engaged in recruitment of participants.
Statistical power, sample size and statistical principles
We expect an effect size of the treatment on symptoms
of depression and anxiety of at least Cohen’s d = 0.30
(a small effect size). This is based on the results from
the ENRICHD study [18]. With α = 0.05 and a power
of 90%, a sample of 468 participants is needed, of
which 234 will receive the intervention. Main results
will be analyzed according to the intention-to-treat
principle and thus include all participants. When ana-
lyzing secondary outcomes, Holm-Bonferroni correc-
tion will compensate for multiple comparisons. The
study is underpowered to detect a potential effect on
major adverse cardiac events and these analyses will
only be exploratory.
Randomization
Participants will be randomized (1:1) to either iCBT or
standard of care. Randomization will be stratified by
clinical center to obtain approximately equal sample sizes
in both groups from every center.
The internet-based cognitive behavioral therapy
intervention
The iCBT intervention is inspired by face-to face CBT
for psychological problems and earlier iCBT-manuals.
CBT is a short-term therapy that aims at challenging
negative patterns of cognitions and behaviors leading to
negative feelings. It usually contains self-registrations
and introduction of new, more functional, cognitions or
behaviors. The iCBT intervention starts with a general
introduction to the CBT model. The participants are
asked to describe their present concerns and goals with
their participation in the treatment. After completing
the introduction, the participants will, with help from
their therapist, choose the problem area(s) they want towork with. This self-tailored design is suggested to give the
participants more control while maintaining treatment
quality [26]. There are 10 treatment modules to choose
from in the portal Each participant chooses two or
three of the modules below after finishing the mandatory
introduction to cognitive behavioral therapy:
 Worry management






 Coping with insomnia
 Values in life
 Relapse prevention.
Each module contains two to four steps, and the partici-
pants are suggested to work with one step each week, for
a total of 14 weeks. The treatment program includes texts,
presentations, assignments, and self-monitoring, and
offers a weekly feedback from a psychologist over the
internet. The content of the modules were designed
specifically for this study.
In addition, the participant can communicate with
their psychologist through the portal at any time and ask
for support or clarifications. Participants who do not log in
or follow the treatment plan are reminded via automatic
emails, text messages, telephone calls, or postal mail at
their choice and are encouraged to continue.
The U-CARE portal also contains a discussion forum
where participants have the possibility to communicate
with each other, as well as videos with patients who have
had an MI and who have struggled with negative feelings
afterwards.
Standard of care
All patients in the study are treated medically according
to international guidelines by the local health care sys-
tem regardless of treatment allocation. Standard of care
includes secondary preventive interventions and cardiac
rehabilitation activities according to local routines.
This includes education about the disease and of risk
factors, encouragement for lifestyle behavioral changes
(for example, smoking cessation, diet modification, and
increased physical activity), and psychosocial support.
Psychotropic medication may be prescribed if considered
necessary.
Procedure
The patients are identified at the local hospitals one to
eight weeks after their MI. The patients are contacted by
project personnel 8 to 12 weeks after their MI and are
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the signed consent form they are provided with login
details. Each participant receives a username and
password that they can change at their own choice.
At each session they will also receive a text message
with a five-digit numerical password to enter, in order to
enhance security. Patients with signs of severe depression
or reporting suicidal ideation when answering the baseline
assessments will be excluded from the study and con-
tacted via telephone by a project psychologist and, if
needed, referred to adequate treatment. Likewise, if there
is reason to believe that they have developed severe
depression or have become suicidal during the study,
patients will be contacted by the psychologist for assess-
ment and possibly referred to other treatment. Reminders
via email and text messages will be sent automatically
from the platform if the questionnaires are not completed
within seven days, and by telephone if they still have not
been completed after another seven days.
The status of depression and/or anxiety for those in
treatment will be monitored by the therapist via commu-
nication within the portal. If there are any indications of
suicidal ideations or worsening of symptoms the therapist
will contact the participant by telephone to evaluate their
status, give advice on how to obtain other treatment or
encourage them to carry on with their iCBT program.
Data collection
Self-rating scales
All self-reported data will be collected via the U-CARE
portal at three time points: (a) at baseline (two months
after the MI), (b) immediately after program completion
(14 weeks after baseline), and (c) during the follow-up
period (12 months after the MI; Figure 1). Well-known
and validated questionnaires with good psychometric
properties reflecting various aspects on psychological
wellbeing will be used.
Depression and anxiety The main outcome measure
assessed is self-reported depression and anxiety using
the HADS [24], which comprises one subscale for
anxiety symptoms and one for depressive symptoms.
Values above seven points on any of the subscales indi-
cate at least mild anxiety or depression. HADS has been
criticized for measuring general distress rather than two
separate symptom clusters [27]; however, anxiety and
depressions are usually correlated even when other
questionnaires are used [28]. The depression subscale of
HADS has been shown to have prognostic value for
morbidity and mortality in patients with acute coronary
syndrome, even though somatic-affective symptom-items
are lacking [29]. Depressive symptoms are also assessed by
the Montgomery-Åsberg Depression Rating Scale-Self-
rating (MADRS-S) [25]. The MADRS-S is also used toscreen for severe depression and/or risk of suicide. To
assess another aspect of depression, passivity and avoid-
ance, the instrument Behavioral Activation for Depression
Scale-Short Form is used [30]. Cardiac anxiety is assessed
by the Cardiac Anxiety Questionnaire (CAQ) [31]. CAQ
measures fear of, avoidance of, and focus on cardiac-
related stimuli and sensations.
Other self-rating scales Quality of life will be assessed
by the EQ-5D [32] and the Cantril Ladder of Life scale
[33]. Time urgency and hostility will be assessed by the
Everyday Life Stress Scale [34], and vital exhaustion will
be assessed using the Maastricht Questionnaire [35].
Sleeping problems will be assessed using the Insomnia
Severity Index [36], and posttraumatic stress will be assessed
with Posttraumatic Stress Disorder Checklist- Civilian
Version [37]. Posttraumatic growth, which refers to
positive psychological change experienced as a result of
struggle with highly challenging life circumstances, will be
assessed with Posttraumatic Growth Inventory-Short
Form [38].
Medical and demographic data
Data on CV morbidity and mortality will be collected
based on information from national registers such as the
Patient Administration Register and the Cause of Death
Register. Clinical data will be obtained by the national
SWEDEHEART registries, which is a framework for
several quality assurance registers in Swedish CV health
care. Events that will be accounted for are: overall and
cardiac-related mortality, including cause of death;
incidence of MI, revascularization and/or stroke; number
of hospitalizations; and number of days in hospital. These
data will be collected at 12 and 24 months post-MI for all
participants in the study. Demographic data will be
obtained via project-specific questions.
Pilot study
Methods
An internal pilot study has been performed using the
same procedures and design as in the main study, and
an evaluation was made after randomization of the first
20 participants. At the time, 12 hospitals were engaged
in the recruitment of participants. The objective of the
pilot study was to evaluate the study acceptability and
participant activity using two criteria; (1) at least 50% of
eligible participants not meeting any exclusion criteria
should accept participation in the study, and (2) at least
50% of the participants randomized to treatment should
have submitted at least one homework assignment
within three weeks. If these criteria were met, the pilot
study would seamlessly proceed to the main study
whilst retaining the pilot participants, in line with the
methodology of internal pilot studies [39].
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The criteria for the pilot were met. Criterion one: 68% of
the eligible patients not meeting any exclusion criteria
accepted participation. The most common exclusion
criterion, matching 35% of the eligible patients, was being
unable or unwilling to use a computer or the internet. Of
the consenting participants that completed the baseline
questionnaires, 21% had HADS scores above seven and
were randomized (see Figure 2). Criterion two: five partici-
pants (50%) submitted at least one homework assignment
within three weeks from randomization. Another two
participants submitted homework assignments eventu-
ally. Three participants were not active at all.
Ethical considerations
The study has been approved by the Regional Ethical
Review Board in Uppsala (approval number: 2011/217).
Written informed consent will be obtained from the
participants before inclusion. Extensive measures have
been taken to minimize the risk of infringing activities,
and to ensure that study participants’ personal data cannot
be linked to patient-reported data by unauthorized
persons. Study participants may at any time terminate
participation without providing any explanation. An365 patients assessed for eligibility 
(met the inclusion criteria)
165 met in
- 18 partic
- 10 had in
- 122 could
- 13 had e
- 2 were to
20 randomized
- 10 to treatment












Figure 2 Pilot study flow chart.important ethical concern is to not include participants in
the study who need other specialized medical care, such
as those with severe depression; the baseline measurement
is designed to minimize that risk. All study participants will
also have an established contact with physicians in routine
health care. If therapists receive information about unex-
pected coronary symptoms they are to inform the patient’s
cardiac clinic after first consulting the study cardiologist.
Discussion
The main result of the internal pilot study was that the
two pre-specified criteria were met and the participants
in the pilot study were included in the main ongoing
study. Even though the criteria were met the data here
presented indicate challenges both in recruitment and
participant engagement. To reach the intended sample
size when taking into account the relatively high rate of
patients matching the exclusion criteria more hospitals
will need to be engaged. Moreover, the power calculation
we have made is conservative, using a high power and low
effect size. A moderate effect size and acceptance of 80%
statistical power will decrease the sample size needed
substantially. We expected more participant engagement
than what was evident from the pilot study. After the pilotitial exclusion criteria
ipated in another study
sufficient Swedish





itten and oral consent but did not fulfill 
easures
experience at least mild symptoms of 
 and/or anxiety (< 8 on both subscales of 
nxiety and Depression Scale)
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protocols at recruitment and when reminding patients.
Minor changes were also made in the structure of the
introduction module. These changes were intended to
improve information dissemination and patient engage-
ment. It would, however, be premature to draw conclusions
about participant engagement from only 10 participants.
Participant engagement is a recognized concern in iCBT
[40] and patient motivation is considered the most import-
ant factor for engagement [41]. In the majority of iCBT
studies participants have been recruited via media cam-
paigns where they actively have sought treatment, whereas
in this study patients were asked if they were interested by
the hospital staff. The lack of externally valid studies is a
major limitation, and therefore this study will clarify
important questions of the feasibility of use of iCBT
for patients with a recent MI in a clinical setting.
The present study is the first RCT using iCBT in patients
with a recent MI with symptoms of depression and anxiety.
If this program is successful, it will have important clinical
implications and open up a possibility to satisfy an unmet
need in these patients. Internet-based treatment has the
potential for large-scale implementation at a reasonable
cost. To increase the generalizability and opportunities for
implementation nationwide, the study will be carried out
in several counties and clinics across Sweden.
Trial status
The inclusion of patients started in September 2013 and
will continue until December 2016.
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